WilmerHale Earns Top Rankings in LMG Life Sciences Guide

Download IconDownload Print IconPrint

WilmerHale Earns Top Rankings in LMG Life Sciences Guide

Client News

Related Solutions

Providing comprehensive solutions for the acquisition, enforcement and protection of IP.
A global team handling highly complex and sensitive matters in all aspects of litigation.
Uncompromising defense of corporations and individuals in high-profile and complex litigation and investigations.

By patenting their innovations, our clients increase the value of their intellectual property and enhance their ability to compete in the marketplace. We work with laboratory and research teams and R&D and product development groups to determine whether, when and where it is in our clients’ business and technical interests to seek patent protection. And we don’t just file patent applications. Drawing on our experience with patent litigation, corporate financings and technology transactions, we implement IP strategies that conserve resources, add measurable value and give our clients a cost-effective and commercially practical competitive edge.

We help clients obtain more than 750 US and foreign patents each year, covering innovations that span the technological spectrum, including aerospace, biochemistry, biotechnology, business methods, chemistry, computer science, fuel cells, genetics, high-speed data communication, integrated circuits, materials science, medical devices, nanotechnology, pharmaceuticals, semiconductor devices and processes, and software.

We also prepare and prosecute patent applications internationally under the Patent Cooperative Treaty and by working with a network of seasoned patent lawyers around the world. Our experience extends to appeals, interferences and opposition proceedings within the US Patent and Trademark Office, the US Court of Appeals for the Federal Circuit and the European Patent Office.

The 2013 edition of LMG Life Sciences has been released, and it includes the recognition of nine WilmerHale practice areas and 17 attorneys. WilmerHale, for the second consecutive year, is also named a 2013 "Lifecycle Firm," meaning the firm is regarded as one of the best, full-service law firms within the life sciences industry.

LMG Life Sciences is a legal directory guide focusing on US law firms and attorneys who work with life sciences companies. This guide, which first hit the market last year, is produced by the Legal Media Group and is divided into multiple categories, covering traditional practice areas that relate to life sciences. Research for the publication was based on reviewing nearly 1,000 interviews and surveys completed by partners who are active in the market. They also spoke with clients and leading lawyers during the research process, in addition to reviewing public information.

WilmerHale is ranked in the following areas (separated by category):

Intellectual Property
Patent Prosecution - Recommended
Patent Strategy & Management - Recommended
Hatch-Waxman Patent Litigation - Recommended
General Patent Litigation - Highly Recommended

Finance & Transactional
Corporate - Recommended
Mega-Merger - Recommended
Licensing & Collaboration (Non-University) - Recommended
Licensing & Collaboration (University) - Highly Recommended

Non-IP Litigation & Enforcement
Government Investigations - Highly Recommended

In addition, the following attorneys have been named "Life Sciences Stars:"

Steven D Barrett 
David B Bassett
Karen F Green 
Robert Gunther 
Brent J  Gurney 
Stephen A Jonas 
William F Lee
Lisa J Pirozzolo
David E Redlick 
Emily R  Schulman 
Mark D Selwyn 
Alfred C Server
Howard M Shapiro 
Steven D Singer 
Colleen Superko 
Michael J Twomey 
Emily R Whelan

To view LMG's complete list of 2013 US law firm and attorney rankings, visit the LMG Life Sciences website.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel